The US FDA has broadened its investigation into AstraZeneca COVID-19 vaccine candidate

Author: Eamonn Sheridan | Category: News

The US Food and Drug Administration iw widening the enquiry, seeking more data from clinical trials

  • FDA seeking raw safety data from clinical trials of similar vaccines developed by same scientists 
  • The FDA does not necessarily indicate a safety problem associated with any of those vaccines

The market has been acting constructively on positive coronavirus vaccine stories. This is not a positive (in the short term at least) so should impact the opposite on risk. 

By continuing to browse our site you agree to our use of cookies, revised Privacy Notice and Terms of Service. More information about cookiesClose